/Investor DB

Canaan Partners — 2019 Investments

14 investments dated 2019 · listed companies and verified rows first · show all

Kustomerkustomer.comin𝕏Series A · Nov 2019 · $10M

Kustomer is an AI-native customer experience (CX) platform that ties every interaction to a complete customer record so AI and human agents can respond with full context, automate conversations, and manage support workflows.

AI & Machine LearningEnterprise SoftwareSaaSSales TechShort Hills, US

Jeremy Suriel(Founder)inBrad Birnbaum(Founder)inMichael Chapin(Executive Officer, Promoter)

BoardScott Beechuk(Director)inAlex Bard(Director)inNeeraj Agrawal(Director)in

Board seatDeepak Kamra· per SEC Form D

Co-investorsAcurio VenturesBattery Venturesboldstart venturesBoxGroupCisco InvestmentsCoatue Management+9 more

Astraastra.cominSeries C · Oct 2019 · $100M

Astra provides dedicated orbital launch services and manufactures electric propulsion systems for satellites.

Defense TechHardwareSpace TechAlameda, US

Chris Kemp(Founder)inDr. Adam London(Founder)Benjamin Lyon(Executive Officer)inMartin Attiq(Executive Officer)inKelyn Brannon(Executive Officer)inLisa Nelson(Director)

Co-investorsACME CapitalBay Bridge Ventures ClimateChenel Capital PartnersEvolution VC PartnersGaingelsHelios Capital+11 more

Bravo Sierrabravosierra.cominAug 2019 · $6.7M

Bravo Sierra makes personal care products, including a sulfate-free body wash with a coconut-derived cleanser, natural oils, and Squalane for hydration and skin barrier protection.

ConsumerDirect to ConsumerE-commerceWellness & FitnessNew York City, US

Benjamin Bernet(Founder)inJustin Guilbert(Founder)

Co-investorsAlumni VenturesBlue Ivy VenturesGrace Beauty CapitalREDO VenturesYadayAF Ventures+3 more

Chimerixchimerix.com𝕏Jul 2019 · $45M

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical DevicesDurham, US

Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)

Co-investorsAisling CapitalAlta PartnersAsset Management CompanyFrazier Life SciencesPappas CapitalSanderling Ventures

Comet Therapeuticscomettherapeutics.cominSeries A · Jun 2019 · $29M

Cambridge, US

ENEJ KUSCER, PH.D.(Executive Officer)PETER VAN VLASSELAER, PH.D.(Director)HENRIJETTE RICHTER, PH.D.(Director)BERNARDUS MACHIELSE(Director)LUCAS DE BREED(Director)DAVID DE GRAAF, PH.D.(Executive Officer, Director)

Co-investorsInkefMission BiocapitalSofinnova Partners

Coteriecoterieparty.com𝕏Pre-Seed · Feb 2019 · $3M

Coterie sells disposable party goods such as paper plates and tableware, offered in designed collections and customizable sets for consumers planning parties.

ConsumerDirect to ConsumerE-commerce

Linden EllisinSara Raffa

Co-investorsFemale FoundersAndreessen Horowitz

Gen.Ggeng.gg𝕏Apr 2019

Gen.G is a professional esports organization that manages competitive teams across multiple games including League of Legends, Valorant, and PUBG, as well as motorsports racing.

Creator EconomyEdTechGamingLos Angeles, US

Arnold Hur(CEO)Kent Wakeford(Founder)Kevin Chou(Founder)

Co-investorsBattery VenturesConductive VenturesDreamers VCGFT VenturesNew Enterprise Associates (NEA)Remarkable Ventures+6 more

Grey Wolf Therapeuticsgreywolftherapeutics.cominSeries A · Feb 2019 · $13M

Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.

BiotechDigital HealthHealthtechMedical DevicesOxford, GB

Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in

Co-investorsAndera PartnersOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalEarlybird Venture CapitalPfizer Ventures

Halda Therapeuticshaldatx.comin𝕏Series A · Feb 2019 · $25M

BiotechMedical DevicesNew Haven, US

Scott Phillips(Executive Officer)in

BoardTim Shannon(Manager)inLiam Ratcliffe(Manager)in

Co-investorsAccess BiotechnologyConnecticut InnovationsElm Street VenturesFrazier Life SciencesRA CapitalTaiho Ventures, LLC+1 more

Pathios Therapeuticspathiostherapeutics.cominSeries A · Dec 2019 · $13M

Pathios Therapeutics is a drug discovery and development company working on small-molecule drugs that block the immune cell receptor GPR65, which senses the acidic tumor microenvironment, with a lead asset (PTT-4256) aimed at treating solid cancers.

BiotechHealthtechMedical DevicesOxford, GB

Alan Naylor(Founder)inStuart Hughes(Chief Scientific Officer)in

Co-investorsBrandon Capital

Players' Loungeplayerslounge.com𝕏Seed · Mar 2019

Players' Lounge is a wagering platform where gamers play money matches, tournaments, and challenges against others for cash prizes.

ConsumerCreator EconomyGamingMarketplacesSports TechNew York City, US

Zach Dixon(Founder)inAustin Woolridge(Founder)inDan Delaney(Founder)inDuncan Lewis(CTO)Deva Kandpal(Vice President of Product)

BoardPierre Planche(Director)in

Co-investorsAlleyCorpComcast VenturesCourtside VenturesDorm RoomEvolution VC PartnersGOAL Ventures+21 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Confetti CollectiveMschf Product Studio IncIntrepida Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.